United Capital Financial Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.24M | Buy |
6,786
+531
| +8% | +$97.8K | 0.01% | 682 |
|
|
2025
Q4 | $1.1M | Buy |
6,255
+822
| +15% | +$134K | 0.01% | 705 |
|
|
2025
Q3 | $761K | Buy |
5,433
+411
| +8% | +$55.6K | 0.01% | 731 |
|
|
2025
Q2 | $631K | Buy |
5,022
+1,644
| +49% | +$205K | 0.01% | 726 |
|
|
2025
Q1 | $462K | Sell |
3,378
-1,496
| -31% | -$214K | ﹤0.01% | 771 |
|
|
2024
Q4 | $745K | Sell |
4,874
-82,501
| -94% | -$13.9M | 0.01% | 623 |
|
|
2024
Q3 | $16.9M | Sell |
87,375
-1,803
| -2% | -$377K | 0.14% | 139 |
|
|
2024
Q2 | $20.7M | Sell |
89,178
-2,198
| -2% | -$478K | 0.18% | 113 |
|
|
2024
Q1 | $19.7M | Sell |
91,376
-3,894
| -4% | -$912K | 0.16% | 124 |
|
|
2023
Q4 | $24.7M | Sell |
95,270
-70,369
| -42% | -$17.3M | 0.2% | 105 |
|
|
2023
Q3 | $42.6M | Sell |
165,639
-21,170
| -11% | -$5.66M | 0.28% | 76 |
|
|
2023
Q2 | $53.2M | Sell |
186,809
-2,767
| -1% | -$824K | 0.29% | 70 |
|
|
2023
Q1 | $52.7M | Sell |
189,576
-2,362
| -1% | -$654K | 0.29% | 70 |
|
|
2022
Q4 | $53.2M | Sell |
191,938
-9,592
| -5% | -$2.71M | 0.3% | 72 |
|
|
2022
Q3 | $53.8M | Sell |
201,530
-1,231
| -0.6% | -$261K | 0.32% | 67 |
|
|
2022
Q2 | $41.4M | Buy |
202,761
+2,942
| +1% | +$601K | 0.23% | 89 |
|
|
2022
Q1 | $42.1M | Buy |
199,819
+39,640
| +25% | +$8.62M | 0.2% | 101 |
|
|
2021
Q4 | $38.4M | Buy |
160,179
+3,538
| +2% | +$910K | 0.18% | 120 |
|
|
2021
Q3 | $44.3M | Buy |
156,641
+3,248
| +2% | +$1.06M | 0.22% | 95 |
|
|
2021
Q2 | $53.1M | Buy |
153,393
+1,197
| +0.8% | +$363K | 0.27% | 75 |
|
|
2021
Q1 | $42.6M | Buy |
152,196
+21,407
| +16% | +$5.77M | 0.24% | 92 |
|
|
2020
Q4 | $32M | Buy |
130,789
+3,583
| +3% | +$924K | 0.19% | 115 |
|
|
2020
Q3 | $36.1M | Buy |
127,206
+9,617
| +8% | +$2.68M | 0.24% | 99 |
|
|
2020
Q2 | $31.5M | Buy |
117,589
+13,943
| +13% | +$4.19M | 0.23% | 100 |
|
|
2020
Q1 | $31.6M | Sell |
103,646
-3,519
| -3% | -$1.07M | 0.26% | 86 |
|
|
2019
Q4 | $31.8M | Buy |
107,165
+7,654
| +8% | +$2.12M | 0.21% | 106 |
|
|
2019
Q3 | $23.2M | Buy |
99,511
+4,523
| +5% | +$1.05M | 0.16% | 144 |
|
|
2019
Q2 | $22.2M | Buy |
94,988
+26,360
| +38% | +$6.09M | 0.15% | 149 |
|
|
2019
Q1 | $16.2M | Buy |
68,628
+5,146
| +8% | +$1.62M | 0.11% | 196 |
|
|
2018
Q4 | $19.1M | Buy |
63,482
+5,680
| +10% | +$1.81M | 0.15% | 141 |
|
|
2018
Q3 | $20.4M | Buy |
57,802
+2,045
| +4% | +$704K | 0.14% | 157 |
|
|
2018
Q2 | $16.2M | Buy |
55,757
+2,576
| +5% | +$724K | 0.12% | 187 |
|
|
2018
Q1 | $14.6M | Buy |
53,181
+2,847
| +6% | +$884K | 0.11% | 205 |
|
|
2017
Q4 | $16.1M | Buy |
50,334
+2,590
| +5% | +$831K | 0.13% | 193 |
|
|
2017
Q3 | $14.9M | Buy |
47,744
+2,743
| +6% | +$812K | 0.13% | 194 |
|
|
2017
Q2 | $12.2M | Buy |
45,001
+6,257
| +16% | +$1.65M | 0.11% | 224 |
|
|
2017
Q1 | $10.6M | Buy |
38,744
+6,156
| +19% | +$1.74M | 0.1% | 246 |
|
|
2016
Q4 | $8.51M | Sell |
32,588
-10,369
| -24% | -$3.07M | 0.08% | 290 |
|
|
2016
Q3 | $13.4M | Buy |
42,957
+4,395
| +11% | +$1.3M | 0.13% | 182 |
|
|
2016
Q2 | $9.33M | Sell |
38,562
-1,183
| -3% | -$312K | 0.1% | 256 |
|
|
2016
Q1 | $10.3M | Buy |
39,745
+2,448
| +7% | +$647K | 0.11% | 193 |
|
|
2015
Q4 | $11.4M | Buy |
37,297
+1,184
| +3% | +$340K | 0.13% | 176 |
|
|
2015
Q3 | $10.5M | Buy |
36,113
+14,732
| +69% | +$4.87M | 0.13% | 178 |
|
|
2015
Q2 | $8.64M | Buy |
21,381
+25
| +0.1% | +$10K | 0.1% | 242 |
|
|
2015
Q1 | $7.99M | Sell |
21,356
-6,719
| -24% | -$2.65M | 0.1% | 260 |
|
|
2014
Q4 | $9.53M | Buy |
28,075
+20,200
| +257% | +$6.53M | 0.14% | 167 |
|
|
2014
Q3 | $2.6M | Buy |
+7,875
| New | +$2.6M | 0.05% | 375 |
|
|
2014
Q2 | – | Sell |
-7,845
| Closed | -$2.4M | – | 803 |
|
|
2014
Q1 | $2.4M | Buy |
7,845
+665
| +9% | +$211K | 0.05% | 329 |
|
|
2013
Q4 | $2.01M | Sell |
7,180
-1,263
| -15% | -$327K | 0.07% | 239 |
|
|
2013
Q3 | $2.03M | Sell |
8,443
-1,339
| -14% | -$300K | 0.06% | 250 |
|
|
2013
Q2 | $2.1M | Buy |
+9,782
| New | +$2.09M | 0.06% | 304 |
|
Other funds holding BIIB
VCM
VPM
United Capital Financial Advisors's BIIB Position: Q1 2026 in Review
United Capital Financial Advisors increased its Biogen (BIIB) stake by 8.5% in Q1 2026, buying an estimated $97.8K and bringing the position to 6,786 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #682.
United Capital Financial Advisors first reported a position in BIIB in Q2 2013 and has held it in 51 quarters since. The position peaked at $53.8M in Q3 2022. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- United Capital Financial Advisors held 6,786 shares of Biogen worth $1.24M as of Q1 2026.
- United Capital Financial Advisors bought 531 Biogen shares in Q1 2026, an estimated $97.8K.
- Biogen made up 0.01% of United Capital Financial Advisors's portfolio in Q1 2026, its #682 holding.
- United Capital Financial Advisors first reported a position in Biogen in Q2 2013 and has held it in 51 quarters since.
- United Capital Financial Advisors's Biogen position peaked at $53.8M in Q3 2022.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.